# Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/peptide-receptor-radionuclide-therapy-with-177lu-dotatate-the-ieo-phase-i-ii/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lisa Bodei,Marta Cremonesi,Chiara Maria Grana,Nicola Fazio,Simona Iodice,Silvia M. Baio,Mirco Bartolomei,Dario Lombardo,Mahila Ferrari,Maddalena Sansovini,Marco Chinol,Giovanni Paganelli |
| Citations | 423 |
| DOI | 10.1007/s00259-011-1902-1 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2027676394 |
| PMID | 21892623 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Lisa Bodei](https://scholariq.org/researchers/lisa-bodei/)

## Paper primary topic

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Paper topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.